EUVIMEDEUVIMED entdecken
Open Access · CC0

Population genetic testing and SERPINA1 sequencing identifies unidentified alpha-1 antitrypsin deficiency alleles and gene-environment interaction with hepatitis C infection

Bryce A Schuler iD, Lisa Bastarache, Janey Wang, Jing He, Sara L Van Driest, Joshua C Denny

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0286469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Bryce A Schuler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin Deficiency, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NICHD NIH HHS, NLM NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha-1 antitrypsin deficiency (AATD), a relatively common autosomal recessive genetic disorder, is underdiagnosed in symptomatic individuals. We sought to compare the risk of liver transplantation associated with hepatitis C infection with AATD heterozygotes and homozygotes and determine if SERPINA1 sequencing would identify undiagnosed AATD. We performed a retrospective cohort study in a deidentified Electronic Health Record (EHR)-linked DNA biobank with 72,027 individuals genotyped for the M, Z, and S alleles in SERPINA1 . We investigated liver transplantation frequency by genotype group and compared with hepatitis C infection. We performed SERPINA1 sequencing in carriers of pathogenic AATD alleles who underwent liver transplantation. Liver transplantation was associated with the Z allele (ZZ: odds ratio [OR] = 1.31, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha 1-Antitrypsin DeficiencyHepatitis CHumansAllelesGene-Environment InteractionRetrospective StudiesHepacivirusGenetics, Populationalpha 1-Antitrypsin

Substanzen

SERPINA1 protein, humanalpha 1-Antitrypsin

Autor:innen und Institutionen

  • Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • All of Us Research Program, National Institutes of Health, Bethesda, Maryland, United States of America.
  • National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

ORCID-Profile: Bryce A Schuler

Förderung

  • NICHD NIH HHS
  • NLM NIH HHS
  • NHLBI NIH HHS
  • U.S. National Library of Medicine
  • National Heart, Lung, and Blood Institute
  • National Human Genome Research Institute

Zitieren

APA

Schuler, B. A., Bastarache, L., Wang, J., He, J., Van Driest, S. L., & Denny, J. C. (2023). Population genetic testing and SERPINA1 sequencing identifies unidentified alpha-1 antitrypsin deficiency alleles and gene-environment interaction with hepatitis C infection. PLOS ONE. https://doi.org/10.1371/journal.pone.0286469

Vancouver

Schuler BA, Bastarache L, Wang J, He J, Van Driest SL, Denny JC. Population genetic testing and SERPINA1 sequencing identifies unidentified alpha-1 antitrypsin deficiency alleles and gene-environment interaction with hepatitis C infection. PLOS ONE. 2023. doi:10.1371/journal.pone.0286469

BibTeX
@article{Schuler2023,
  author = {Schuler, Bryce A and Bastarache, Lisa and Wang, Janey and He, Jing and Van Driest, Sara L and Denny, Joshua C},
  title = {Population genetic testing and SERPINA1 sequencing identifies unidentified alpha-1 antitrypsin deficiency alleles and gene-environment interaction with hepatitis C infection},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0286469}
}
Kostenlos starten →